two or more distinct coronary lesions with two or more coronary stents deployed in two or more coronary segments, or a bifurcation lesion requiring angioplasty and/or stenting in both the main artery and the side branch ), 92945 ( Percutaneous transluminal revascularization of chronic total occlusion, single coronary artery, coronary artery branch, or coronary artery bypass graft, and/or subtended major coronary artery branches of the bypass graft any combination of intracoronary stent, atherectomy and angioplasty
Patients on prolonged INH therapy often receive supplemental pyridoxine to prevent peripheral neuropathy, an adverse effect related to B deficiency
Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease
According to ProHealth's published company information, all products are manufactured in the United States in facilities subject to FDA dietary supplement current Good Manufacturing Practice (cGMP) requirements under 21 CFR Part 111
/images/2025/03/06/80a97023-8cda-4f9b-9f34-acfd82496b14.png)
